ITGA1 and neoplasm: Our data demonstrate that, the intralymphatically administered E7-TriMix vaccine induces antigen-specific T cells that are attracted to and retain within the tumour tissue despite the fact that they do not express mucosa-associated markers such as CD103 and CD49a.